X

pharmaceuticals

Earnings: AbbVie (ABBV) Q3 profit rises, beats estimates on higher revenues

Biopharmaceutical company AbbVie Inc. (NYSE: ABBV) on Friday said its third-quarter revenues and net profit increased from last year. The…

Merck beats market estimates in Q3: Infographic

Merck (NYSE: MRK) reported third-quarter 2021 financial results before the regular market hours on Thursday. The pharmaceutical giant reported Q3…

Johnson & Johnson (JNJ) reports Q3 2021 earnings

Johnson & Johnson (NYSE: JNJ) reported third-quarter 2021 financial results before the regular market hours on Tuesday. The pharmaceutical giant…

Abbott (ABT) bets on product mix to stay strong. Should you buy the stock?

The healthcare industry remains stressed despite a marked improvement in the pandemic situation, with patient visits increasing steadily and elective…

Infographic: How Tilray (TLRY) performed in Q1 2022

Tilray (NASDAQ: TLRY) reported first-quarter 2022 financial results after the regular market hours on Thursday. Total net revenue increased 43%…

Infographic: Highlights of Aurora Cannabis (ACB) Q4 2021 earnings report

Aurora Cannabis, Inc. (NYSE: ACB) on Monday reported a net loss for the fourth quarter of 2021, continuing the recent…

Trxade Health Inc. (NASDAQ: MEDS) Q3 2021 Research Summary

It is estimated that the North American e-Pharmacy market would grow at a compound annual rate of 14.8% through 2025.…

Medicure Inc (MPH) Q2 2021 Earnings Call Transcript

Medicure Inc (CVE:MPH) Q2 2021 earnings call dated Aug. 30, 2021. Corporate Participants: Albert D. Friesen -- Chief Executive Officer…

Mayne Pharma Group Ltd (MYX) Q4 2021 Earnings Call Transcript

Mayne Pharma Group Ltd (ASX:MYX) Q4 2021 earnings call dated Aug. 26, 2021. Corporate Participants: Scott Richards -- Chief Executive…

IPO News: Should you invest in RenovoRx’s upcoming IPO?

As healthcare startups continue to flock to the stock market, extending the hectic activity seen in the first half, the…

Should you buy Agilent Technologies (A) stock ahead of next week’s earnings?

The impact of the COVID crisis on Agilent Technologies, Inc. (NYSE: A), a leading provider of medical diagnostic devices, has…

IPO News: What to look for when Eliem Therapeutics goes public?

Extending the IPO frenzy that sweeped the market in the early part of the year, emerging biotechnology companies continue to…

CVS Health Corp. (CVS) Earnings: 2Q21 Key Numbers

VS Health Corporation (NYSE: CVS) reported second-quarter 2021 earnings results today. Total revenues increased 11.1% to $72.6 billion compared to…

IPO News: What awaits Adagio Therapeutics after stock market debut?

The favorable regulatory environment and convenient options like direct listing continue to lure emerging businesses to the stock market. The…

IPO News: Here’s everything you need to know about Healthcare Royalty’s upcoming IPO

In the first half of 2021, a record number of private companies entered stock markets in the US, marking a…

Merck & Co., Inc. (MRK) Q2 2021 Earnings Call Transcript

Merck & Co., Inc. (NYSE: MRK) Q2 2021 earnings call dated Jul. 29, 2021 Corporate Participants: Peter Dannenbaum -- Vice President, Investor…

Infographic: Highlights of Merck & Co. (MRK)Q2 2021 earnings report

Merck & Co., Inc. (NYSE: MRK) reported earnings and sales for the second quarter of 2021. Worldwide sales edged up…

Pfizer (PFE) expects to manufacture up to 3 billion doses of COVID vaccine by end of this year

Shares of Pfizer Inc. (NYSE: PFE) were up 3.5% on Wednesday after the pharma giant reported second quarter 2021 revenue…

Pfizer, Inc. (PFE) Q2 2021 Earnings Call Transcript

Pfizer, Inc. (NYSE: PFE) Q2 2021 Earnings call dated Jul. 28, 2021 Corporate Participants: Christopher Stevo -- Senior Vice President, Chief Investor…

WCG Clinical IPO: Here’s what you should know before investing in the stock

Of late healthcare firms have been flocking to Wall Street, betting on the booming stock market to take their business…

Teva Pharmaceutical Industries Ltd (TEVA) Q2 2021 Earnings Call Transcript

Teva Pharmaceutical Industries Ltd (NYSE: TEVA) Q2 2021 earnings call dated Jul. 28, 2021. Corporate Participants: Kevin C. Mannix -- Senior…